TORONTO--(BUSINESS WIRE)--BioPharma Services is proud to once again be the recipient of the CRO Leadership Award. This year, BioPharma has been recognized with awards in five categories: Capabilities, Compatibility, Expertise, Quality and Reliability. Renzo Dicarlo, CEO will be accepting the Award from Life Science Leader at the annual CRO Leadership Awards presentation which takes place during the upcoming DIA Global Annual Meeting in San Diego.
On receiving notification of the Awards, Renzo Dicarlo enthused, “We are humbled to be recognized by our peers in a record five categories of the CRO Leadership Awards. BioPharma’s commitment to deliver excellence in early stage research is reaffirmed daily by an empowered team that always goes the extra mile while delivering world class clinical solutions for our clients. I could not be more proud today of this achievement”.
Anna Taylor, BioPharma’s Executive Vice President Business Development noted, “Inspired performance, quality and innovation are the hallmarks of BioPharma. Every day, the team strives to develop leading-edge healthcare solutions and essential medical therapies for the global pharmaceutical community and most recently has been responsible for our groundbreaking Phase I and Human Abuse Potential service offerings. Receiving these Awards cements BioPharma Services as a true leader in this niche market”.
For the 2019 Awards, Life Science Leader magazine once again teamed up with Industry Standard Research (ISR) to determine the award recipients. More than 70 contract research organizations were assessed on 20+ performance metrics in ISR’s annual CRO Quality Benchmarking survey. Survey participants were recruited from Pharma and Biopharma companies of all sizes and were screened for decision-making influence related to working with contract research organizations. Respondents only evaluate companies with which they have worked on an outsourced project within the past 18 months. This level of qualification ensures that survey responses are based on actual involvement with CROs and clear experiential data.
About BioPharma Services Inc.
BioPharma Services Inc. is a full-service Contract Research Organization (CRO) specializing in the conduct of Phase I/IIa and Bioequivalence clinical trials for international pharmaceutical companies worldwide. BioPharma has clinical facilities both in the USA and Canada with a total capacity of 300 beds with access to healthy volunteers and special populations. Headquartered in Toronto, Canada, BioPharma’s comprehensive services also include Bioanalysis at our GLP Certified Laboratory, Scientific and Regulatory Affairs, Biostatistics and Safety Data Analysis (CDISC), Medical Writing and Data Management.